Cognitive Decline clinical trials

Explore recruiting cognitive decline clinical trials.

Recruiting cognitive decline studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cognitive Decline trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Multicentre, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Effect of a 30-week Caffeine Treatment on Cognition in Alzheimer's Disease at Beginning to Moderate Stages. Effect of CAFeine on Cognition in Alzheimer's Disease ( CAFCA )

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Effectiveness of CITicoline (TRAUSAN) in preventing cognitive decline After DELirium in older adults with proximal hip fracture – The CITADEL randomized controlled trial

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Alpha 2 adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): randomised controlled trial

Norway

Phase III and phase IV (Integrated) EU CTIS Study details

Amyloid pathology in cognitively normal elderly subjects (PreclinAD)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, placebo-controlled, double-blind Phase 3 study to evaluate the efficacy, safety and tolerability of votoplam in participants with Huntington’s Disease

Netherlands, Denmark, Slovakia

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, double-blind, placebo-controlled, 104-week proof-of-concept study to evaluate the efficacy of intravenous prasinezumab in participants with Parkinson's disease carrying a severe mutation in the GBA gene (prevent cognitive decline in GBA-associated PD)

Spain, Germany, Italy, Sweden, France, Luxembourg

Therapeutic exploratory (Phase II) EU CTIS Study details

Cognitive Decline trials by city

Cognitive Decline in Toronto Cognitive Decline in Vancouver Cognitive Decline in Montreal Cognitive Decline in Calgary Cognitive Decline in Edmonton Cognitive Decline in Ottawa Cognitive Decline in Winnipeg Cognitive Decline in Quebec City Cognitive Decline in Hamilton Cognitive Decline in Kitchener Cognitive Decline in London Cognitive Decline in Halifax Cognitive Decline in New York Cognitive Decline in Los Angeles Cognitive Decline in Chicago Cognitive Decline in Houston

Cognitive Decline clinical trials

Recruiting cognitive decline studies right now

Dance Intervention to Improve Executive Function and Physical Performance in Older Adults With Cognitive Impairment

Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)

Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment

Isolated Versus Combined Cognitive and Motor High-tech Rehabilitation

A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment

TREAD: Time Restricted Eating Intervention for Alzheimer's Disease

Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol

Dual Task Perturbation Training for OAwMCI

Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)

The Brain Health PRO Online Risk Factor Reduction Study to Prevent Dementia

Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease

Links Between Cognitive Deficits During Normal or Pathological Aging and Slow Waves Measured in EEG

Also recruiting in Europe

Multicentre, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Effect of a 30-week Caffeine Treatment on Cognition in Alzheimer's Disease at Beginning to Moderate Stages. Effect of CAFeine on Cognition in Alzheimer's Disease ( CAFCA )

Effectiveness of CITicoline (TRAUSAN) in preventing cognitive decline After DELirium in older adults with proximal hip fracture – The CITADEL randomized controlled trial

Alpha 2 adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): randomised controlled trial

Amyloid pathology in cognitively normal elderly subjects (PreclinAD)

A randomized, placebo-controlled, double-blind Phase 3 study to evaluate the efficacy, safety and tolerability of votoplam in participants with Huntington’s Disease

A randomized, double-blind, placebo-controlled, 104-week proof-of-concept study to evaluate the efficacy of intravenous prasinezumab in participants with Parkinson's disease carrying a severe mutation in the GBA gene (prevent cognitive decline in GBA-associated PD)

Cognitive Decline trials by city

Other conditions